Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

This study has been completed.
Information provided by:
Valeant Pharmaceuticals International, Inc. Identifier:
First received: May 27, 2011
Last updated: July 17, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)